🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well the combination of botensilimab, balst...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06575725
The objective of this study is to evaluate the efficacy and safety of cryoa...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-26
Trial ID
NCT05057052
Treatments Being Tested
To learn about the effects of the drugs regorafenib and lorigerlimab on cir...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-02-11
Trial ID
NCT07071961
Treatments Being Tested
The association of doublet chemotherapy (FOLFOX and FOLFIRI) and anti-EGFR-...
Status
Completed
Location
U.O. Oncologia 2 Universitaria
Start Date
2020-12-15
Trial ID
NCT04787341
Treatments Being Tested
Regorafenib is an oral medication that can interfere with cancer cell growt...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-03
Trial ID
NCT02098538
Treatments Being Tested
This study is a prospective, randomized controlled, multicenter clinical st...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-01
Trial ID
NCT05233358
This phase II/III trial compares the effect of vincristine, irinotecan, and...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2025-11-10
Trial ID
NCT06820957
Treatments Being Tested
Regorafenib is a valuable treatment option for metastatic colorectal cancer...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-10
Trial ID
NCT01996969
Treatments Being Tested
This phase I/II trial tests how well botensilimab, balstilimab, and regoraf...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-05-11
Trial ID
NCT05672316
Treatments Being Tested
The objective of this randomized placebo-controlled Phase 2 study is to eva...
Status
Unknown
Location
Saiseikai Fukuoka General Hospital
Start Date
2014-10
Trial ID
NCT02288078
Treatments Being Tested